Cargando…
Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427565/ https://www.ncbi.nlm.nih.gov/pubmed/27094235 http://dx.doi.org/10.1016/j.bjid.2016.03.006 |
| _version_ | 1784778933644820480 |
|---|---|
| author | Okumura, Lucas Miyake |
| author_facet | Okumura, Lucas Miyake |
| author_sort | Okumura, Lucas Miyake |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9427565 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94275652022-09-01 Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective Okumura, Lucas Miyake Braz J Infect Dis Letter to the Editor Elsevier 2016-04-16 /pmc/articles/PMC9427565/ /pubmed/27094235 http://dx.doi.org/10.1016/j.bjid.2016.03.006 Text en © 2016 Elsevier Editora Ltda. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter to the Editor Okumura, Lucas Miyake Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective |
| title | Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective |
| title_full | Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective |
| title_fullStr | Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective |
| title_full_unstemmed | Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective |
| title_short | Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective |
| title_sort | protease inhibitors and azolic antifungals in hiv patients with histoplasmosis: a clinical pharmacokinetics perspective |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427565/ https://www.ncbi.nlm.nih.gov/pubmed/27094235 http://dx.doi.org/10.1016/j.bjid.2016.03.006 |
| work_keys_str_mv | AT okumuralucasmiyake proteaseinhibitorsandazolicantifungalsinhivpatientswithhistoplasmosisaclinicalpharmacokineticsperspective |